Dr. Gagnon’s research is focused on identifying and characterizing genetic and epigenetic determinants of chronic diseases in specific populations, with efforts geared toward developing novel study designs integrating emerging genetic and epigenetic technologies and sophisticated statistical methodologies. Through an enhanced understanding of the genetic architecture and underlying biological mechanisms of chronic diseases, the ultimate goal of her research program is the prevention and management of these complex conditions. Dr. Gagnon’s current research includes the study of venous thromboembolism and hemostatic traits – a group of traits that influence individuals’ risk for several common chronic disorders including cardiovascular disease and metabolic syndrome.
Dr. Gagnon is committed to community and capacity building in genetic epidemiology in Canada and abroad. She is the nominated Principal Investigator and Co-Director of the CIHR training program STAGE - Strategic Training for Advanced Genetic Epidemiology, Canada’s first formal and comprehensive training program in Genetic Epidemiology and Statistical Genetics. She is also a founding member of the Scientific Advisory Committee for the Montreal School of Population Genomics and Genetic Epidemiology, and serves as Canadian Ambassador and member of the Board of Directors of the International Genetic Epidemiology Society.